DSE : LIBRAINFU

Libra Infusions Limited — Company profile

Pharmaceutical Preparations · Bangladesh

Last price 555.9 BDT (At close: Nov 1, 2026) · Market cap 1.25B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Company profile

Libra Infusions Limited manufactures and sells intravenous fluids in Bangladesh. Its products are used in medical situations, including diarrhoeal disease, surgical operation, loss of blood, weakness, and hospitalization. The company offers LIBOTT, LIBOTT-10, LIBOTT-25, LIBOTT-S, LIBOTT-S JR, NORMASOL, BABY SALINE, DIASOL, HARTSOL, LIBRAZOL, LIBRACIN, LIBOTT-M, LIBRACIN-400, and LIBRET products. The company was formerly known as Libra Pharmaceutical Limited and changed its name to Libra Infusions Limited in 1999. Libra Infusions Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

Details

NameLibra Infusions Limited
IndustryPharmaceutical Preparations
Employees699
Founded1976
CeoRoushon Alam
CountryBangladesh
ExchangeDhaka Stock Exchange
Fiscal YearJuly - June
Reporting CurrencyBDT
IsinBD0471LBINF8
Sic2834

Key executives

NameTitle
Roushon AlamChief Executive Officer
A. N. MainuddinChief Financial Officer

Contact

AddressI/7 Mirpur Industrial Estate, Dhaka, 1216, Bangladesh
Phone880 2 4804 0254
Websitehttps://libragroupbd.com/libra_infusions.php